Dirk Reitsma, MD

Trials that address multiple questions simultaneously using a master protocol can be operationally complicated. These complexities can be managed, even in studies used to support a marketing application.

How the practical application of these methods can help overcome the complex demands of cancer trials.

Today’s rich oncology pipeline-accounting for nearly 25% of agents in clinical development-promises much needed advances in cancer therapy.